| abstract |
Methods of treating neurological disorders, e.g., those characterized by demyelination and/or axonal loss (e.g., MS), are provided. The methods comprise administration of a therapeutically effective amount of at least one compound of Formula I: n n n n n n n n n n wherein R 1 and R 2 are independently selected from OH, O − , and (C 1-6 )alkoxy, or a pharmaceutically acceptable salt thereof; and either glatiramer acetate or interferon-beta. |